Double-blind clinical trial of sertraline treatment for alcohol dependence / Helen Pettinati en Journal of Clinical Psychopharmacology, Año 2001 - Vol. 21 - No. 2 (Abril)

Público ISBD [artículo]  inJournal of Clinical Psychopharmacology > Año 2001 - Vol. 21 - No. 2 (Abril) . - pp. 143-153 Título : Double-blind clinical trial of sertraline treatment for alcohol dependence Tipo de documento: texto impreso Autores: Helen Pettinati, Autor ; Joseph R. Volpicelli, Autor ; Gary Luck, Autor Fecha de publicación: 2023 Artículo en la página: pp. 143-153 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Alcoholismo, Trastorno depresivo, Diagnóstico Dual, Inhibidores selectivos de la recaptación de serotonina. Resumen: Clinical studies that have evaluated serotonergic medications to reduce alcohol consumption have yielded conflicting results. These studies primarily treated patients with alcohol dependence, excluding those with a current depressive disorder, in an effort to differentiate any medication effects directly on drinking from those on mood. Link: ./index.php?lvl=notice_display&id=31118 [artículo] Double-blind clinical trial of sertraline treatment for alcohol dependence [texto impreso] / Helen Pettinati, Autor ; Joseph R. Volpicelli, Autor ; Gary Luck, Autor . - 2023 . - pp. 143-153. Idioma : Inglés (eng) Idioma original : Inglés (eng) in Journal of Clinical Psychopharmacology > Año 2001 - Vol. 21 - No. 2 (Abril) . - pp. 143-153 Palabras clave: Alcoholismo, Trastorno depresivo, Diagnóstico Dual, Inhibidores selectivos de la recaptación de serotonina. Resumen: Clinical studies that have evaluated serotonergic medications to reduce alcohol consumption have yielded conflicting results. These studies primarily treated patients with alcohol dependence, excluding those with a current depressive disorder, in an effort to differentiate any medication effects directly on drinking from those on mood. Link: ./index.php?lvl=notice_display&id=31118

A multi-site dose ranging study of nalmefene in the treatment of alcohol dependence / Raymond F. Anton en Journal of Clinical Psychopharmacology, Año 2004 - Vol. 24 - No. 4 (Agosto)

Público ISBD [artículo]  inJournal of Clinical Psychopharmacology > Año 2004 - Vol. 24 - No. 4 (Agosto) . - pp. 421-428 Título : A multi-site dose ranging study of nalmefene in the treatment of alcohol dependence Tipo de documento: texto impreso Autores: Raymond F. Anton, Autor ; Helen Pettinati, Autor ; Allen Zweben, Autor Fecha de publicación: 2023 Artículo en la página: pp. 421-428 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Alcoholismo, Relación Dosis-Respuesta, Naltrexona - efectos adversos Resumen: The opiate antagonist nalmefene has been shown in 2 single-site studies to reduce alcohol consumption and relapse drinking in alcohol-dependent individuals. This safety and preliminary multisite efficacy study evaluated 3 doses of nalmefene (5, 20, or 40 mg) in a double-blind comparison to placebo over a 12-week treatment period in 270 recently abstinent outpatient alcohol-dependent individuals. Link: ./index.php?lvl=notice_display&id=30956 [artículo] A multi-site dose ranging study of nalmefene in the treatment of alcohol dependence [texto impreso] / Raymond F. Anton, Autor ; Helen Pettinati, Autor ; Allen Zweben, Autor . - 2023 . - pp. 421-428. Idioma : Inglés (eng) Idioma original : Inglés (eng) in Journal of Clinical Psychopharmacology > Año 2004 - Vol. 24 - No. 4 (Agosto) . - pp. 421-428 Palabras clave: Alcoholismo, Relación Dosis-Respuesta, Naltrexona - efectos adversos Resumen: The opiate antagonist nalmefene has been shown in 2 single-site studies to reduce alcohol consumption and relapse drinking in alcohol-dependent individuals. This safety and preliminary multisite efficacy study evaluated 3 doses of nalmefene (5, 20, or 40 mg) in a double-blind comparison to placebo over a 12-week treatment period in 270 recently abstinent outpatient alcohol-dependent individuals. Link: ./index.php?lvl=notice_display&id=30956

---

1 (1 - 2 / 2)